Life-threatening acute adverse cutaneous drug reactions

Clinics in Dermatology

Volumn 23, Issue 2, 2005, Pages 171-181

  Wolf, Ronni ^a   Orion, Edith ^a   Marcos, Batsheva ^a   Matz, Hagit ^b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMINOPENICILLIN; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; CAPTOPRIL; CARBAMAZEPINE; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; CORTICOSTEROID; HYDANTOIN DERIVATIVE; IMIDAZOLE; IMMUNOGLOBULIN G; LAMOTRIGINE; MACROGOL; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PETROLATUM; PHENOBARBITAL; PHENYTOIN; POLYMACON; POVIDONE IODINE; QUINOLONE DERIVATIVE; SILVER NITRATE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TUBERCULOSTATIC AGENT; UNINDEXED DRUG; VALPROIC ACID;

ANAPHYLAXIS; ARTHRALGIA; CLINICAL FEATURE; DERMATOLOGY; DISEASE CLASSIFICATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EOSINOPHILIA; FEVER; HUMAN; HYPERSENSITIVITY; INTENSIVE CARE UNIT; LABORATORY TEST; LYMPHADENOPATHY; MORBIDITY; MORTALITY; OUTPATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SERUM SICKNESS; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; VASCULITIS;

EID: 15744373165     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2004.06.012     Document Type: Article

References (169)

1. L.L. Leape, T.A. Brennan, and N. Laird The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II N. Engl. J. Med. 324 1991 377 384
2. J. Hallas, B. Harvald, and L.F. Gram Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention J. Intern. Med. 228 1990 83 90
3. T.R. Einarson Drug-related hospital admissions Ann. Pharmacother. 27 1993 832 840
4. F. Fiszenson-Albala, V. Auzerie, and E. Mahe A 6-month prospective survey of cutaneous drug reactions in a hospital setting Br. J. Dermatol. 149 2003 1018 1022
5. M. Bigby, S. Jick, and H. Jick Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982 JAMA 256 1986 3358 3363
6. K. Alanko, S. Stubb, and K. Kauppinen Cutaneous drug reactions: clinical types and causative agents. A five-year survey of in-patients (1981-1985) Acta Derm. Venereol. 69 1989 223 226
7. T. Ives, E. Bentz, and R. Gwyther Dermatologic adverse drug reactions in a family medicine setting Arch. Fam. Med. 1 1992 241 245
8. P. Fabbri, and E. Panconesi Erythema multiforme ("minus" and "maius") and drug intake Clin. Dermatol. 11 1993 479 489
9. A. Stevens, and F. Johnson A new eruptive fever associated with stomatitis and ophthalmia Am. J. Dis. Child. 24 1922 526
10. B. Thomas The so-called Stevens-Johnson syndrome Br. Med. J. 1 1950 1393 1397
11. A. Lyell Toxic epidermal necrolysis: an eruption resembling scalding of the skin Br. J. Dermatol. 68 1956 355 361
12. A. Lyell Drug-induced toxic epidermal necrolysis: I. An overview Clin. Dermatol. 11 1993 491 492
13. R. Tomb, and E. Grosshans The rediscovery of previously described dermatoses Arch. Dermatol. 137 2001 715 718
14. G. Ritter von Rittershain Die exfoliateve Dermatitis jungerer Sauglinge Centralzeit Kinderheilk 2 1878 3 23
15. R. Debre, M. Lamy, and M. Lamotte Un cas d'erythrodermie avec epidermolyse chez un enfant de 12 ans Bull. Soc. Pediatr. Paris 37 1939 231 238
16. S. Bastuji-Garin, B. Rzany, and R.S. Stern Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme Arch. Dermatol. 129 1993 92 96
17. J. Rasmussen Toxic epidermal necrolysis Med. Clin. North Am. 64 1980 901 920
18. O. Chosidow, J.C. Delchier, and M.T. Chaumette Intestinal involvement in drug-induced toxic epidermal necrolysis Lancet 337 1991 928
19. J.F. Timsit, G. Mion, and N. Rouyer Bronchopulmonary distress associated with toxic epidermal necrolysis Intensive Care Med. 18 1992 42 44
20. C. Bombal, J.C. Roujeau, and M. Kuentz Hematologic anomalies in Lyell's syndrome. Study of 26 cases Ann. Dermatol. Venereol. 110 1983 113 119
21. J.F. Timsit, G. Mion, and Y. Le Gulluche Severe hypothermia occurring during the course of toxic epidermal necrolysis in patients treated with air-fluidized beds Arch. Dermatol. 127 1991 739 740
22. J.F. Timsit, G. Mion, and Y. Le Gulluche Hypothermia and air-fluidized beds during toxic epidermal necrolysis management Intensive Care Med. 17 1991 506
23. R. Forman, G. Koren, and N.H. Shear Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience Drug Saf. 25 2002 965 972
24. S. Magina, C. Lisboa, and V. Leal Dermatological and ophthalmological sequels in toxic epidermal necrolysis Dermatology 207 2003 33 36
25. J.C. Roujeau, S. Moritz, and J.C. Guillaume Lymphopenia and abnormal balance of T-lymphocyte subpopulations in toxic epidermal necrolysis Arch. Dermatol. Res. 277 1985 24 27
26. J. Goens, M. Song, and P. Fondu Haematological disturbances and immune mechanisms in toxic epidermal necrolysis Br. J. Dermatol. 114 1986 255 259
27. J. Kvasnicka, J. Rezac, and J. Svejda Disseminated intravascular coagulation associated with toxic epidermal necrolysis (Lyell's syndrome) Br. J. Dermatol. 100 1979 551 558
28. M.D. Kamaliah, D. Zainal, and N. Mokhtar Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in northeastern Malaysia Int. J. Dermatol. 37 1998 520 523
29. O. Chosidow, Z. el Wady, and M. Devanlay Hyperamylasemia in toxic epidermal necrolysis Arch. Dermatol. 129 1993 792 793
30. L. Blum, O. Chosidow, and G. Rostoker Renal involvement in toxic epidermal necrolysis J. Am. Acad. Dermatol. 34 1996 1088 1090
31. J.C. Roujeau, J.P. Kelly, and L. Naldi Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis N. Engl. J. Med. 333 1995 1600 1607
32. B. Rzany, O. Correia, and J.P. Kelly Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions Lancet 353 1999 2190 2194
33. I. Garcia-Doval, L. LeCleach, and H. Bocquet Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch. Dermatol. 136 2000 323 327
34. T. McGee, and A. Munster Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center Plast. Reconstr. Surg. 102 1998 1018 1022
35. R.H. Demling, S. Ellerbe, and N.J. Lowe Burn unit management of toxic epidermal necrolysis Arch. Surg. 113 1978 758 759
36. J.C. Roujeau, and J. Revuz Intensive care in dermatology R. Champion R. Pye Recent advances in dermatology 1990 Churchill Livingstone Edinburgh 85 99
37. W.J. Power, M. Ghoraishi, and J. Merayo-Lloves Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum Ophthalmology 102 1995 1669 1676
38. G. Anhalt, and C.F. Snelling Toxic epidermal necrolysis. Case report Plast. Reconstr. Surg. 61 1978 905 910
39. A. Bjornberg Fifteen cases of toxic epidermal necrolysis (Lyell) Acta Derm. Venereol. 53 1973 149 152
40. K. Ohlenschlaeger Toxic epidermal necrolysis and Stevens-Johnson's disease Acta Derm. Venereol. 46 1966 204 209
41. E.F. Sherertz, B.V. Jegasothy, and G.S. Lazarus Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy" J. Am. Acad. Dermatol. 12 1985 178 181
42. R. Patterson, M.S. Dykewicz, and A. Gonzalzles Erythema multiforme and Stevens-Johnson syndrome. Descriptive and therapeutic controversy Chest 98 1990 331 336
43. J.S. Prendiville, A.A. Hebert, and M.J. Greenwald Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children J. Pediatr. 115 1989 881 887
44. M.J. Tegelberg-Stassen, W.A. van Vloten, and H. Baart de la Faille Management of nonstaphylococcal toxic epidermal necrolysis: follow-up study of 16 case histories Dermatologica 180 1990 124 129
45. R. Patterson, L.C. Grammer, and P.A. Greenberger Stevens-Johnson syndrome (SJS): effectiveness of corticosteroids in management and recurrent SJS Allergy Proc. 13 1992 89 95
46. S. Cheriyan, R. Patterson, and P.A. Greenberger The outcome of Stevens-Johnson syndrome treated with corticosteroids Allergy Proc. 16 1995 151 155
47. J.E. Rasmussen Erythema multiforme in children. Response to treatment with systemic corticosteroids Br. J. Dermatol. 95 1976 181 186
48. J.E. Rasmussen Toxic epidermal necrolysis. A review of 75 cases in children Arch. Dermatol. 111 1975 1135 1139
49. P. Halebian, V.J. Corder, and D. Herndon A burn center experience with toxic epidermal necrolysis J. Burn Care Rehabil. 4 1983 176 183
50. P.H. Halebian, V.J. Corder, and M.R. Madden Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids Ann. Surg. 204 1986 503 512
51. W.G. Jones, P. Halebian, and M. Madden Drug-induced toxic epidermal necrolysis in children J. Pediatr. Surg. 24 1989 167 170
52. P.H. Halebian, and G.T. Shires Burn unit treatment of acute, severe exfoliating disorders Annu. Rev. Med. 40 1989 137 147
53. J.J. Kelemen III, W.G. Cioffi, and W.F. McManus Burn center care for patients with toxic epidermal necrolysis J. Am. Coll. Surg. 180 1995 273 278
54. R.L. Sheridan, J.M. Weber, and J.T. Schulz Management of severe toxic epidermal necrolysis in children J. Burn Care Rehabil. 20 1999 497 500
55. R. Abe, T. Shimizu, and A. Shibaki Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand Am. J. Pathol. 162 2003 1515 1520
56. I. Viard, P. Wehrli, and R. Bullani Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 282 1998 490 493
57. M. Stella, P. Cassano, and D. Bollero Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience Dermatology 203 2001 45 49
58. P. Tristani-Firouzi, M.J. Petersen, and J.R. Saffle Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children J. Am. Acad. Dermatol. 47 2002 548 552
59. A. Tan, H.H. Tan, and C.C. Lee Treatment of toxic epidermal necrolysis in AIDS with intravenous immunoglobulins Clin. Exp. Dermatol. 28 2003 269 271
60. C. Prins, C. Vittorio, and R.S. Padilla Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: a retrospective, multicenter study Dermatology 207 2003 96 99
61. C. Prins, F.A. Kerdel, and R.S. Padilla Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases Arch. Dermatol. 139 2003 26 32
62. J.T. Trent, R.S. Kirsner, and P. Romanelli Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami experience Arch. Dermatol. 139 2003 39 43
63. R.U. Sidwell, S. Swift, and C.L. Yan Treatment of toxic epidermal necrolysis with intravenous immunoglobulin Int. J. Clin. Pract. 57 2003 643 645
64. N. Bachot, J. Revuz, and J.C. Roujeau Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression Arch. Dermatol. 139 2003 33 36
65. H. Merrit, and T. Putnam Sodium diphenylhydantoinate in treatment of convulsive disorders: toxic symptoms and their prevention Arch. Neurol. Psychiatry 42 1939 1053 1058
66. N.H. Shear, and S.P. Spielberg Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk J. Clin. Invest. 82 1988 1826 1832
67. F. Haruda Phenytoin hypersensitivity: 38 cases Neurology 29 1979 1480 1485
68. K.J. Tomecki, and C.J. Catalano Dapsone hypersensitivity. The sulfone syndrome revisited Arch. Dermatol. 117 1981 38 39
69. R. Wolf, A. Tamir, and N. Werbin Methyldopa hypersensitivity syndrome Ann. Allergy 71 1993 166 168
70. S.R. Knowles, L. Shapiro, and N.H. Shear Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature Arch. Dermatol. 132 1996 934 939
71. H. Bocquet, M. Bagot, and J.C. Roujeau Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug eruption with eosinophilia and systemic symptoms: DRESS) Semin. Cutan. Med. Surg. 15 1996 250 257
72. R.G. Schlienger, and N.H. Shear Antiepileptic drug hypersensitivity syndrome Epilepsia 39 1998 S3 S7
73. P. Tennis, and R.S. Stern Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study Neurology 49 1997 542 546
74. S.R. Knowles, L.E. Shapiro, and N.H. Shear Anticonvulsant hypersensitivity syndrome: incidence, prevention and management Drug Saf. 21 1999 489 501
75. O. Bessmertny, and T. Pham Antiepileptic hypersensitivity syndrome: clinicians beware and be aware Curr. Allergy Asthma Rep. 2 2002 34 39
76. A.S. De Vriese, J. Philippe, and D.M. Van Renterghem Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature Medicine (Baltimore) 74 1995 144 151
77. A.E. Cribb, B.L. Lee, and L.A. Trepanier Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis Adverse Drug React. Toxicol. Rev. 15 1996 9 50
78. H. Hamanaka, H. Mizutani, and N. Nouchi Allopurinol hypersensitivity syndrome: hypersensitivity to oxypurinol but not allopurinol Clin. Exp. Dermatol. 23 1998 32 34
79. L.M. Sommers, and R.B. Schoene Allopurinol hypersensitivity syndrome associated with pancreatic exocrine abnormalities and new-onset diabetes mellitus Arch. Intern. Med. 162 2002 1190 1192
80. W. O'Brien, and G. Bagby Rare adverse reactions to nonsteroidal antiinflammatory drugs J. Rheumatol. 12 1985 347 353
81. L. Crantock, R. Prentice, and L. Powell Cholestatic jaundice associated with captopril therapy J. Gastroenterol. Hepatol. 6 1991 528 530
82. P. Baylor, and K. Williams Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy Clin. Infect. Dis. 29 1999 1350 1351
83. J. Grosset, and S. Leventis Adverse effects of rifampin Rev. Infect. Dis. 5 1983 S440 S450
84. R.I. Cascaval, and D.J. Lancaster Hypersensitivity syndrome associated with azithromycin Am. J. Med. 110 2001 330 331
85. S. Rebollo, P. Sanchez, and J.M. Vega Hypersensitivity syndrome from isoniazid with positive patch test Contact Dermatitis 45 2001 306
86. S. Knowles, A.K. Gupta, and N.H. Shear The spectrum of cutaneous reactions associated with diltiazem: three cases and a review of the literature J. Am. Acad. Dermatol. 38 1998 201 206
87. J. Warnock, and D. Morris Adverse cutaneous reactions to mood stabilizers Am. J. Clin. Dermatol. 4 2003 21 30
88. A. Raz, R. Bergman, and O. Eilam A case report of olanzapine-induced hypersensitivity syndrome Am. J. Med. Sci. 321 2001 156 158
89. K.J. Tomecki, and C.J. Catalano Dapsone hypersensitivity. The sulfone syndrome revisited Arch. Dermatol. 117 1981 38 39
90. A.K. Gupta, and A.J. Porges Hypersensitivity syndrome reaction to oral terbinafine Australas. J. Dermatol. 39 1998 171 172
91. R. Wolf, A. Tamir, and N. Werbin Methyldopa hypersensitivity syndrome Ann. Allergy 71 1993 166 168
92. H.A. Ward, G.G. Russo, and J. Shrum Cutaneous manifestations of antiretroviral therapy J. Am. Acad. Dermatol. 46 2002 284 293
93. G.A. Kennebeck Anticonvulsant hypersensitivity syndrome J. Am. Board Fam. Pract. 13 2000 364 370
94. M. Baba, M. Karakas, and V.L. Aksungur The anticonvulsant hypersensitivity syndrome J. Eur. Acad. Dermatol. Venereol. 17 2003 399 401
95. O. Scheuerman, Y. Nofech-Moses, and A. Rachmel Successful treatment of antiepileptic drug hypersensitivity syndrome with intravenous immune globulin Pediatrics 107 2001 E14
96. V.J. Green, M. Pirmohamed, and N.R. Kitteringham Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity Biochem. Pharmacol. 50 1995 1353 1359
97. L. Crantock, R. Prentice, and L. Powell Cholestatic jaundice associated with captopril therapy J. Gastroenterol. Hepatol. 6 1991 528 530
98. W.A. Parker, and C.A. Shearer Phenytoin hepatotoxicity: a case report and review Neurology 29 1979 175 178
99. A.R. Morkunas, and M.B. Miller Anticonvulsant hypersensitivity syndrome Crit. Care Clin. 13 1997 727 739
100. U. Mahadeva, M. Al Mrayat, and K. Steer Fatal phenytoin hypersensitivity syndrome Postgrad. Med. J. 75 1999 734 736
101. C.C. Vittorio, and J.J. Muglia Anticonvulsant hypersensitivity syndrome Arch. Intern. Med. 155 1995 2285 2290
102. F.C. Fervenza, S. Kanakiriya, and R.T. Kunau Acute granulomatous interstitial nephritis and colitis in anticonvulsant hypersensitivity syndrome associated with lamotrigine treatment Am. J. Kidney Dis. 36 2000 1034 1040
103. J. Hegarty, M. Picton, and G. Agarwal Carbamazepine-induced acute granulomatous interstitial nephritis Clin. Nephrol. 57 2002 310 313
104. M.J. Robbie, J.P. Scurry, and P. Stevenson Carbamazepine-induced severe systemic hypersensitivity reaction with eosinophilia Drug Intell. Clin. Pharm. 22 1988 783 784
105. B.D. Klassen, and R.M. Sadler Induction of hypersensitivity to a previously tolerated antiepileptic drug by a second antiepileptic drug Epilepsia 42 2001 433 435
106. V.J. Anttila, and M. Valtonen Carbamazepine-induced eosinophilic colitis Epilepsia 33 1992 119 121
107. I.A. Eland, A.S. Dofferhoff, and R. Vink Colitis may be part of the antiepileptic drug hypersensitivity syndrome Epilepsia 40 1999 1780 1783
108. L.F. De Swert, J.L. Ceuppens, and D. Teuwen Acute interstitial pneumonitis and carbamazepine therapy Acta Paediatr. Scand. 73 1984 285 288
109. N. Takahashi, H. Aizawa, and S. Takata Acute interstitial pneumonitis induced by carbamazepine Eur. Respir. J. 6 1993 1409 1411
110. D.L. Nathan, and D.V. Belsito Carbamazepine-induced pseudolymphoma with CD-30 positive cells J. Am. Acad. Dermatol. 38 1998 806 809
111. V. Descamps, E. Mahe, and N. Houhou Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection Br. J. Dermatol. 148 2003 1032 1034
112. P.R. Daniels, G.J. Berry, and H.D. Tazelaar Giant cell myocarditis as a manifestation of drug hypersensitivity Cardiovasc. Pathol. 9 2000 287 291
113. Y. Fujino, M. Nakajima, and H. Inoue Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome Ann. Neurol. 51 2002 771 774
114. Y. Bourezane, D. Salard, and B. Hoen DRESS (drug eruption with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy Clin. Infect. Dis. 27 1998 1321 1322
115. M. Lanzafame, P. Rovere, and G. DeChecchi Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy Scand. J. Infect. Dis. 33 2001 475 476
116. E. Knudtson, M. Para, and H. Boswell Drug eruption with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus Obstet. Gynecol. 101 2003 1094 1097
117. R. Stalnikowicz, M. Mosseri, and O. Shalev Phenytoin-induced arthritis Neurology 32 1982 1317 1318
118. P. Carfagna, E. Pistella, and V. Paravati Arthritis as a rare side effect of phenytoin therapy Eur. J. Intern. Med. 12 2001 448 450
119. A. Verrotti, C. Feliciani, and S. Morresi Carbamazepine-induced hypersensitivity syndrome in a child with epilepsy Int. J. Immunopathol. Pharmacol. 13 2000 49 53
120. J.R. Michael, and W.E. Mitch Reversible renal failure and myositis caused by phenytoin hypersensitivity JAMA 236 1976 2773 2775
121. J. Harney, and M.R. Glasberg Myopathy and hypersensitivity to phenytoin Neurology 33 1983 790 791
122. A.P. Knutsen, M. Shah, and K.B. Schwarz Graft versus host-like illness in a child with phenobarbital hypersensitivity Pediatrics 78 1986 581 584
123. A. Gupta, M.C. Eggo, and J.P. Uetrecht Drug-induced hypothyroidism: the thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides Clin. Pharmacol. Ther. 51 1992 56 67
124. V. Callot, J.C. Roujeau, and M. Bagot Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities Arch. Dermatol. 132 1996 1315 1321
125. T.S. Choi, K.S. Doh, and S.H. Kim Clinicopathological and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome Br. J. Dermatol. 148 2003 730 736
126. P.D. Ghislain, and J.C. Roujeau Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome Dermatol. Online J. 8 2002 5
127. S. Tas, and T. Simonart Management of drug eruption with eosinophilia and systemic symptoms (DRESS syndrome): an update Dermatology 206 2003 353 356
128. C. von Pirquet, and B. Schick Die Serumkrankheit 1905 Deuticke Leipzig
129. E.D. Ralph, M. John, and M.J. Rieder Serum sickness-like reaction possibly associated with meropenem use Clin. Infect. Dis. 36 2003 E149 E151
130. A.J. Tatum, A.M. Ditto, and R. Patterson Severe serum sickness-like reaction to oral penicillin drugs: three case reports Ann. Allergy Asthma Immunol. 86 2001 330 334
131. J. Martin, and G. Abbott Serum sickness like illness and antimicrobials in children N. Z. Med. J. 108 1995 123 124
132. F.M. Parra, M.J. Perez Elias, and M. Cuevas Serum sickness-like illness associated with rifampicin Ann. Allergy 73 1994 123 125
133. B. King, and G. Geelhoed Adverse skin and joint reactions associated with oral antibiotics in children: the role of cefaclor in serum sickness-like reactions J. Paediatr. Child Health 39 2003 677 681
134. G.I. Joubert, K. Hadad, and D. Matsui Selection of treatment of cefaclor-associated urticarial, serum sickness-like reactions and erythema multiforme by emergency pediatricians: lack of a uniform standard of care Can J. Clin. Pharmacol. 6 1999 197 201
135. R. Phillips New warning about cefaclor and serum sickness in children Aust. Fam. Physician 28 1999 539
136. T. Vial, J. Pont, and E. Pham Cefaclor-associated serum sickness-like disease: eight cases and review of the literature Ann. Pharmacother. 26 1992 910 914
137. J. Yerushalmi, A. Zvulunov, and S. Halevy Serum sickness-like reactions Cutis 69 2002 395 397
138. S. Malakar, S. Dhar, and M.R. Shah Is serum sickness an uncommon adverse effect of minocycline treatment? Arch. Dermatol. 137 2001 100 101
139. M. Landau, E. Shachar, and S. Brenner Minocycline-induced serum sickness-like reaction J. Eur. Acad. Dermatol. Venereol. 14 2000 67 68
140. O. Elkayam, M. Yaron, and D. Caspi Minocycline-induced autoimmune syndromes: an overview Semin. Arthritis Rheum. 28 1999 392 397
141. L. Grasset, C. Guy, and M. Ollagnier Cyclines and acne: pay attention to adverse drug reactions! A recent literature review Rev. Med. Interne 24 2003 305 316
142. L.E. Shapiro, S.R. Knowles, and N.H. Shear Fluoxetine-induced serum sickness-like reaction Ann. Pharmacother. 31 1997 927
143. A. Vincent, M. Douville, and P. Baruch Serum sickness induced by fluoxetine Am. J. Psychiatry 148 1991 1602 1603
144. E. Wooltorton Bupropion (Zyban, Wellbutrin SR): reports of deaths, seizures, serum sickness CMAJ 166 2002 68
145. R.A. McCollom, D.H. Elbe, and A.H. Ritchie Bupropion-induced serum sickness-like reaction Ann. Pharmacother. 34 2000 471 473
146. G. Sanchez, L. Vila, and M. Pajaron Skin manifestations of a case of phenylbutazone-induced serum sickness-like reactions J. Investig. Allergol. Clin. Immunol. 10 2000 170 172
147. C.D. Brooks Sulfasalazine for the management of juvenile rheumatoid arthritis J. Rheumatol. 28 2001 845 853
148. Y. Herishanu Rituximab-induced serum sickness Am. J. Hematol. 70 2002 329
149. L. Bielory, P. Gascon, and T.J. Lawley Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure Medicine (Baltimore) 67 1988 40 57
150. J.M. Andersen, and J.J. Tiede Serum sickness associated with 6-mercaptopurine in a patient with Crohn's disease Pharmacotherapy 17 1997 173 176
151. M. Mannik Serum sickness and pathophysiology of immune complexes R. Rich T. Flwisher B. Schwartz Clinical immunology principles and practice 1996 Mosby-Year Book Inc St. Louis 1062 1071
152. T. Hunziker, U.P. Kunzi, and S. Braunschweig Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey Allergy 52 1997 388 393
153. M. Bigby, S. Jick, and H. Jick Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982 JAMA 256 1986 3358 3363
154. S. Stubb, H. Heikkila, and K. Kauppinen Cutaneous reactions to drugs: a series of in-patients during a five-year period Acta Derm. Venereol. 74 1994 289 291
155. R. Apaydin, N. Bilen, and S. Dokmeci Drug eruptions: a study including all inpatients and outpatients at a dermatology clinic of a university hospital [letter] J. Eur. Acad. Dermatol. Venereol. 14 2000 518 520
156. A. Barbaud, S. Reichert-Penetrat, and P. Trechot The use of skin testing in the investigation of cutaneous adverse drug reactions Br. J. Dermatol. 139 1998 49 58
157. V.K. Sharma, and S. Dhar Clinical pattern of cutaneous drug eruption among children and adolescents in north India Pediatr. Dermatol. 12 1995 178 183
158. S. Puavilai, and C. Choonhakarn Drug eruptions in Bangkok: a 1-year study at Ramathibodi Hospital Int. J. Dermatol. 37 1998 747 751
159. L. Naldi, A. Conforti, and M. Venegoni Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions Br. J. Clin. Pharmacol. 48 1999 839 846
160. M. Bigby Rates of cutaneous reactions to drugs Arch. Dermatol. 137 2001 765 770
161. B.S. Bochner, and L.M. Lichtenstein Anaphylaxis N. Engl. J. Med. 324 1991 1785 1790
162. E. Nettis, M. Marcandrea, and G. Maggio Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients Immunopharmacol. Immunotoxicol. 23 2001 585 595
163. J.E. Erffmeyer Penicillin allergy Clin. Rev. Allergy 4 1986 171 188
164. O. Idsoe, T. Guthe, and R. Willcox Nature and extent of penicillin side-reactions, with particular reference to fatalities from anapylactic shock Bull. WHO 38 1968 159 188
165. International Rheumatic Fever Study Group Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever Lancet 337 1991 1308 1310
166. E. Ekenstam, and J.P. Callen Cutaneous leukocytoclastic vasculitis. Clinical and laboratory features of 82 patients seen in private practice Arch. Dermatol. 120 1984 484 489
167. N.P. Sanchez, H.M. Van Hale, and W.P. Su Clinical and histopathologic spectrum of necrotizing vasculitis. Report of findings in 101 cases Arch. Dermatol. 121 1985 220 224
168. J.C. Jennette, and R.J. Falk Small-vessel vasculitis N. Engl. J. Med. 337 1997 1512 1523
169. I.R. Edwards, and J.K. Aronson Adverse drug reactions: definitions, diagnosis, and management Lancet 356 2000 1255 1259